explore -WSS

explore

author：fashion 2025-08-25 07:29:23 - browse：58661

Anna Yeo/STAT

Recently approved gene therapies offer patients one-time, potentially curative treatments for genetic diseases such as sickle cell anemia and beta thalassemia. But “one-time” miracle solutions can often be multi-month affairs, require millions of dollars, and cause painful side effects. What if that doesn’t have to be the case?

In utero gene editing, or prenatal somatic cell genome editing, envisions treating a fetus diagnosed with a genetic disease before birth, thereby preventing that entire protocol and the onset of symptoms in the first place. It would also challenge the need for the ethically fraught enterprise of embryo editing, as the treatment would only make edits in the DNA of the individual fetus — edits which would not be passed on in a heritable way.

Watch this video to learn more about in utero gene editing, how it works, and why scientists believe it might be an advantageous approach to treating certain genetic diseases.

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Merck drug for rare lung condition set for approval in U.S.

focus

explore

WSS

Merck drug for rare lung condition set for approval in U.S.

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Texas Department of Public Safety speaks out on migrant abuse allegations

Key lawmaker blasts Congress’ efforts on addiction: ‘Shame on us’

Oprah kicked off a national conversation on obesity. Let's have it

Readout LOUD podcast: mifepristone case, GLP

hotspot

explore

hotspot

The high cost of giving birth even with insurance

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

Alkermes shareholders re

Readout LOUD podcast: mifepristone case, GLP

The cancer drug shortage isn’t new — and neither are the solutions

Senate committee advances SCOTUS ethics bill after alleged justice misconduct

Drug repurposing or repositioning? The language matters

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Decaf coffee targeted by food safety group under obscure FDA rule

hotspot

Primary care physicians play key roles in Alzheimer's management

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

Washington mulls new rules to avert another Change Healthcare

Stanford president's case begs question: Who takes blame?

There's no autism epidemic. It's an autism diagnosis epidemic

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

hotspot

focus

explore

hotspot